Monitoring of B Cell in Kidney Transplantation: Development of a Novel Clusters Analysis and Role of Transitional B Cells in Transplant Outcome.
B cell clusters
acute rejection
forensic pathology
kidney transplant
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
01 Apr 2021
01 Apr 2021
Historique:
received:
06
02
2021
revised:
21
03
2021
accepted:
27
03
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
B lymphocytes (BL) seem to play an important role in transplantation, although the and role of different subpopulations in monitoring and outcome is not clear. Our aim was to monitoring immunological profiles based on BL subpopulations in kidney recipients (KR) with the risk of acute rejection (AR). Monitoring of BL subpopulations was performed by flow cytometry in PBLs before transplantation and three and six months after transplantation (PTX). We used two methodological approaches, a traditional analysis, and a novel cluster analysis, to determine the association between BL subpopulations, AR incidence, and graft function. After three months of PTX, KRs with a B phenotype enriched in transitional BL and plasmablasts had better kidney function and lower AR incidence. KRs with decreased transitional BL and plasmablasts were associated with lower kidney function and higher AR PTX. KRs that had an increase in transitional BL PTX had a better clinical outcome. The increase in transitory BL during PTX was also associated with an increase in Tregs. Indeed, KRs receiving thymoglobulin as induction therapy showed a slight decrease in the relative frequency of naive BLs after three months of PTX. The monitoring of BL subpopulations may serve as a non-invasive tool to improve immunological follow-up of patients after kidney transplantation. However, further studies are needed to confirm the obtained results, define cut-off values, and standardize more optimal and even custom/customized protocols.
Sections du résumé
BACKGROUND
BACKGROUND
B lymphocytes (BL) seem to play an important role in transplantation, although the and role of different subpopulations in monitoring and outcome is not clear. Our aim was to monitoring immunological profiles based on BL subpopulations in kidney recipients (KR) with the risk of acute rejection (AR).
METHODS
METHODS
Monitoring of BL subpopulations was performed by flow cytometry in PBLs before transplantation and three and six months after transplantation (PTX). We used two methodological approaches, a traditional analysis, and a novel cluster analysis, to determine the association between BL subpopulations, AR incidence, and graft function.
RESULTS
RESULTS
After three months of PTX, KRs with a B phenotype enriched in transitional BL and plasmablasts had better kidney function and lower AR incidence. KRs with decreased transitional BL and plasmablasts were associated with lower kidney function and higher AR PTX. KRs that had an increase in transitional BL PTX had a better clinical outcome. The increase in transitory BL during PTX was also associated with an increase in Tregs. Indeed, KRs receiving thymoglobulin as induction therapy showed a slight decrease in the relative frequency of naive BLs after three months of PTX.
CONCLUSION
CONCLUSIONS
The monitoring of BL subpopulations may serve as a non-invasive tool to improve immunological follow-up of patients after kidney transplantation. However, further studies are needed to confirm the obtained results, define cut-off values, and standardize more optimal and even custom/customized protocols.
Identifiants
pubmed: 33916199
pii: diagnostics11040641
doi: 10.3390/diagnostics11040641
pmc: PMC8065535
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI15/01370
Organisme : Instituto de Salud Carlos III
ID : P19/01194
Organisme : European Union with European Fund of Regional Development (FEDER)
ID : "A manner to build Europe"
Références
Kidney Int. 2015 May;87(5):984-95
pubmed: 25629549
Cell Death Dis. 2018 Jan 25;9(2):109
pubmed: 29371592
J Immunol Res. 2019 Jan 8;2019:7452019
pubmed: 30729139
Autoimmunity. 2014 Feb;47(1):1-12
pubmed: 24245950
Nat Immunol. 2000 Dec;1(6):475-82
pubmed: 11101868
Cancer Res. 2013 Apr 15;73(8):2468-79
pubmed: 23384943
J Am Soc Nephrol. 2014 Jul;25(7):1575-85
pubmed: 24610932
DNA Cell Biol. 2017 Oct;36(10):870-877
pubmed: 28829194
Transplantation. 2011 May 15;91(9):1010-8
pubmed: 21403590
Transplantation. 2005 Jun 15;79(11):1507-15
pubmed: 15940039
Transpl Immunol. 2014 May;30(4):159-67
pubmed: 24709525
PLoS One. 2016 Apr 05;11(4):e0153170
pubmed: 27045291
BMB Rep. 2015 Jan;48(1):54-9
pubmed: 25341924
PLoS One. 2014 Nov 13;9(11):e112658
pubmed: 25393622
Transplant Res. 2013 Oct 25;2(1):17
pubmed: 24160259
Inflamm Res. 2009 Jul;58(7):345-57
pubmed: 19262989
Am J Transplant. 2008 Mar;8(3):600-7
pubmed: 18294156
Am J Transplant. 2014 Jan;14(1):144-55
pubmed: 24354874
Nat Rev Nephrol. 2019 Jan;15(1):11-26
pubmed: 30443016
World J Transplant. 2015 Dec 24;5(4):196-208
pubmed: 26722647
Am J Nephrol. 2013;37(6):586-601
pubmed: 23774740
Am J Transplant. 2015 May;15(5):1384-91
pubmed: 25808898
Immunity. 2015 Apr 21;42(4):607-12
pubmed: 25902480
J Immunol. 2017 Jan 15;198(2):927-936
pubmed: 27986910
Transpl Int. 2016 May;29(5):540-8
pubmed: 26839984
Arthritis Res Ther. 2012 Feb 08;14(1):R32
pubmed: 22315945
Immunology. 2012 Jun;136(2):198-207
pubmed: 22321054
Postepy Hig Med Dosw (Online). 2017 Apr 12;71(0):254-266
pubmed: 28402253
Am J Transplant. 2010 Sep;10(9):2132-2141
pubmed: 20883548
Am J Transplant. 2017 Feb;17(2):542-550
pubmed: 27529836
Kidney Int. 2008 Sep;74(5):664-73
pubmed: 18547992
J Immunol. 2016 Feb 1;196(3):1400-11
pubmed: 26746188
Clin Exp Immunol. 2021 Feb;203(2):315-328
pubmed: 33025622
Am J Transplant. 2015 Nov;15(11):2908-20
pubmed: 26461968
Kidney Int. 2017 Jan;91(1):183-195
pubmed: 28029430